Detalhe da pesquisa
1.
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.
Cell
; 175(1): 85-100.e23, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30173916
2.
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Proc Natl Acad Sci U S A
; 120(3): e2207291120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634138
3.
Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis: A Nationwide Cost-Effectiveness Study.
Ann Neurol
; 95(6): 1099-1111, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529711
4.
A Genetic Risk Variant for Multiple Sclerosis Severity is Associated with Brain Atrophy.
Ann Neurol
; 94(6): 1080-1085, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37753809
5.
Impact of previous treatment history and B-cell depletion treatment duration on infection risk in relapsing-remitting multiple sclerosis: a nationwide cohort study.
J Neurol Neurosurg Psychiatry
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744458
6.
Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy.
J Neurol Neurosurg Psychiatry
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744460
7.
Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study.
J Neurol Neurosurg Psychiatry
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538059
8.
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.
J Neurol Neurosurg Psychiatry
; 95(2): 134-141, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558400
9.
Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
J Neurol Neurosurg Psychiatry
; 95(2): 125-133, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748927
10.
Lower complement C1q levels in first-episode psychosis and in schizophrenia.
Brain Behav Immun
; 117: 313-319, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301948
11.
Clinical and neuroimaging phenotypes of autoimmune glial fibrillary acidic protein astrocytopathy: A systematic review and meta-analysis.
Eur J Neurol
; : e16284, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506182
12.
Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment.
Eur J Neurol
; 31(5): e16229, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321574
13.
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.
Clin Chem Lab Med
; 62(2): 322-331, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702323
14.
Small noncoding RNA profiling across cellular and biofluid compartments and their implications for multiple sclerosis immunopathology.
Proc Natl Acad Sci U S A
; 118(17)2021 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879606
15.
Cerebrospinal fluid levels of neuroinflammatory biomarkers are increased in athletes with persistent post-concussive symptoms following sports-related concussion.
J Neuroinflammation
; 20(1): 189, 2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592277
16.
Spasticity treatment patterns among people with multiple sclerosis: a Swedish cohort study.
J Neurol Neurosurg Psychiatry
; 94(5): 337-348, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539267
17.
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 726-737, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076291
18.
Immunological protein profiling of first-episode psychosis patients identifies CSF and blood biomarkers correlating with disease severity.
Brain Behav Immun
; 111: 376-385, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146654
19.
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia.
Mol Psychiatry
; 27(8): 3247-3261, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618883
20.
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.
Mult Scler
; 29(6): 731-740, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37073483